Hemogenomics Private Limited, a active private limited company, was established on 22 January 2002 in Bangalore., Karnataka, India. Engaging in diagnostic centers & pathology labs within the hospital and medical care sector, it holds CIN: U73100KA2002PTC030032. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹4.00 Cr and a paid-up capital of ₹2.23 Cr.
It upholds a compliant status. Employing 99 professional, Its leadership includes Anurag Bagaria (Director), Sumit Bagaria (Managing Director), Francisco Jose Dopazo Gonzalez (Additional Director). Past directors included William J Rutter, Ashok Sekhar Ganguly, Anurag Bagaria. It holds ₹68.54 Cr open charges and no settled loans. Its latest AGM occurred on 20 September 2024, with the balance sheet filed on 31 March 2024. It is based at Kemwell House,No.11, Tumkur Road Bangalore., Bangalore., Karnataka, 560022.
U73100KA2002PTC030032
030032
22 January 2002
₹4.00 Cr
₹2.23 Cr
Roc Bangalore
Unlisted
Active
Explore comprehensive insights into Hemogenomics Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Anurag Bagaria | Director | 08 Mar 2010 | Current |
| Sumit Bagaria | Managing Director | 18 Jan 2011 | Current |
| Francisco Jose Dopazo Gonzalez | Additional Director | 10 Jan 2025 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 10 Jan 2025 | Past |
| Pramod Abcsdd | Director | 11 Nov 2010 | Past |
| Pramod Abcsdd | Additional Director | 23 Sep 2010 | Past |
| Pramod Abcsdd | Director | 07 Apr 2015 | Past |
| Pramod Abcsdd | Nominee Director | 19 Mar 2010 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Hemogenomics Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 44.71% increase. The company also saw a substantial improvement in profitability, with a 131.56% increase in profit. The company's net worth Soared by an impressive increase of 12.82%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Hemogenomics had a promoter holding of 65.02% and a public holding of 34.99%. The company had 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹685,366,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Jun 2025 | The Hongkong And Shanghai Banking Corporation Limited | ₹27.50 Cr | Open |
| 20 Feb 2025 | Others | ₹1.04 Cr | Open |
| 02 Mar 2016 | Citi Bank N.A. | ₹5.00 Cr | Open |
| 11 Jan 2012 | Citi Bank N.A. | ₹35.00 Cr | Open |
Explore comprehensive loan charge details -
Hemogenomics has a workforce of 99 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Hemogenomics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hemogenomics's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
A charge with The Hongkong And Shanghai Banking Corporation Limited amounted to Rs. 27.50 Cr with Charge ID 101118743 was registered on 28 Jun 2025. was recorded as a recent event.
Progress on A charge with Others amounted to Rs. 1.04 Cr with Charge ID 101080855 was registered on 20 Feb 2025. was documented.
The activity Francisco Jose Dopazo Gonzalez was appointed as a Additional Director was appointed as a Additional Director on 10 Jan 2025 & has been associated with this company since 10 months 15 days . was completed.
Progress on Hemogenomics Private Limited last Annual general meeting of members was held on 20 Sep 2024 as per latest MCA records. was documented.
Progress on Hemogenomics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Bangalore. was documented.
The activity A charge with Citi Bank N.A. of Rs. 35.00 Cr registered on 11 Jan 2012 with Charge ID 10337103 was modified on 15 Feb 2022. was completed.
The CIN of Hemogenomics Private Limited is U73100KA2002PTC030032.
Hemogenomics Private Limited is headquartered at Kemwell House,No.11, Tumkur Road Bangalore., Bangalore., Karnataka, 560022.
Hemogenomics Private Limited was incorporated on 22 January 2002.
The current directors of Hemogenomics Private Limited are
The primary industry of Hemogenomics Private Limited is Hospital And Medical Care.
Hemogenomics Private Limited is unlisted.
The authorized capital of Hemogenomics Private Limited is ₹4.00 Cr, and the paid-up capital is ₹2.23 Cr.
The compliance status of Hemogenomics Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX